History
2020’s
2025
- Launched ‘Chroma M-Cell’
- Awarded a Commendation from the Minister of Health and Welfare for contributions to the development of the medical device industry
- Signed a contract to establish a Stem Cell Clinic Center in the Bali Medical Special Economic Zone (SEZ), Indonesia
2024
- Developed ‘Chroma Therapy’
- Participated in EFORT 2024, Europe’s largest congress for orthopaedics and traumatology
- Recognized as a promising company under the Global Small Giants 1000+ Project, organized by the Ministry of SMEs and Startups
- Participated in ESSKA 2024 (European Society of Sports Traumatology, Knee Surgery & Arthroscopy)
- Participated in AMWC MONACO 2024 (Aesthetic & Anti-Aging Medicine World Congress)
- Participated in AAOS 2024 (American Academy of Orthopaedic Surgeons Annual Meeting)
- Participated in IMCAS 2024, the world’s largest congress for aesthetic and plastic surgery
2023
- Extended NET (New Excellent Technology) Certification in the healthcare sector (valid through February 2025)
- Selected as a Next-Generation World-Class Product by the Ministry of Trade, Industry and Energy (MOTIE)
- Completed self-registration as a New Medical Technology for bone marrow stem cell injection therapy in knee osteoarthritis patients (Ministry of Health and Welfare Notice No. 2023-128, Item No. 918)
2022
- Awarded a Commendation from the Minister of Trade, Industry and Energy for R&D in new medical technologies
- Participated in KIMES 2022, Korea’s largest exhibition for medical devices
- Conducted joint clinical research on treatment for chronic renal failure patients
- Collaborative research conducted with Konkuk University Hospital and five other institutions
- Participated in ARAB HEALTH 2022, an international medical device exhibition
- Completed preparations for FD approval (planned)
2021
- Developed a knee cartilage scaffold through joint research with International St. Mary’s Hospital
- Domestic clinical studies on neurological and vascular diseases in collaboration with Hanyang University and other institutions
- Participated in MEDICA 2021, the world’s largest international medical device exhibition
- Received a Commendation from the Prime Minister at the Korea New Growth Management Awards
- Received the Minister of Food and Drug Safety Award in the Innovative Medical Device category
- Selected as a national leader in government-led healthcare and diagnostics innovation
- Obtained NET (New Excellent Technology) Certification for a bone marrow blood stem cell extraction device featuring a selectively separable centrifuge container
2020
- Launched a new stem cell cosmetic product ‘CELLPIA Ampoule 100,’ containing 100% stem cell culture medium
- Launched Korea’s first cell extraction and storage service through a television shopping network
(LOTTE Home Shopping)
- Obtained CE Certification
- Designated as a Promising Export Firm (No. 2020-Seoul-45)
- Named an ‘Innovative Brand and Idea Product’ at the Seoul Awards, organized by the Seoul Business Agency (SBA)
- Launched immune cell and stem cell storage service plans
2010’s
2019
- Launched new stem cell cosmetic products: CELLPIA Blanc Booster and Blanc Mask
- Launched SMART M-CELL 2, an advanced convergent medical device
- Received the Minister of Science and ICT Award
- Received the Minister of SMEs and Startups Award
- Developed the stem cell–specialized global platform ‘CELLPIA Global Platform’
- Introduced technology for the production of mesenchymal stem cell (MSC) culture media–based products
- Obtained ISO 22716 certification for Good Manufacturing Practices in cosmetics
- Signed a US 2.6 million dollar export contract for stem cell cosmetics to Vietnam
- Launched stem cell–based cosmetic products at LOTTE Duty Free (Ginza, Japan) and Arai Resort
2018
- Launched new stem cell cosmetic products, including CELLPIA Ampoule, CELLPIA Sunblock, and Cell Protein Cream
(8 product variants)
- Received the Minister of Science, ICT and Future Planning Award
- Obtained ISO 13485 and ISO 9001 certifications for medical device quality management systems
- Obtained GMP certification for medical device manufacturing and quality management
- Received the Minister of Health and Welfare Award
- Signed export contracts for cosmetics to China
- Entered sales agency agreements for cosmetics and cell-banking services (Health In Cell)
- Signed a technology transfer agreement with the Catholic University of Korea for product development using mesenchymal stem cell (MSC) culture media
- Signed a development agreement for a hair care set designed to help prevent gray hair
2017
- Launched the placenta-based ‘Protein Vital Day/Night Cream’
- Commenced exports of stem cell cosmetic products
- Began cosmetic exports to Hong Kong and Singapore
- Company name changed to MIRACELL CO., LTD.
- Completed the development of minimally manipulated stem cell isolation and expansion core technologies
(bone marrow and blood)
- Selected for the SME Commercialization Technology Development Program by the Ministry of SMEs and Startups
- Developed and commenced in-house production of stem cell isolation, concentration, and expansion devices and kits (GMP certified)
2016
- Certified as ‘Venture Business’
- Selected for the Growth-Oriented Technology Company Incubation Program
- Launched stem cell cosmetic products, including SCCM BB Cream and SCCM Hand Cream
2015
- Launched stem cell banking services
- Appointed as the exclusive distributor in Korea for Cytori Therapeutics, Inc. (USA), covering adipose-derived stem cell technologies including the Celution® Stem Cell Extraction System
- Established a stem cell bio research institute
2014
- Approved as a New Medical Technology for indications including cartilage regeneration, bone union, osteochondritis dissecans of the knee, and critical limb ischemia
(including occlusive peripheral arterial disease and diabetic foot ulcers)
- Approved as a New Medical Technology for acute myocardial infarction indications following percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) by the KFDA
2013
- Awarded the 2013 Korea Brand Award
- Approved as a New Medical Technology for indications including cartilage regeneration, bone fusion, osteochondritis dissecans of the knee, and critical limb ischemia
2012
- Awarded the 2012 Medical Korea Grand Prize
- Official notice by the Ministry of Health and Welfare:
Final approval following safety and efficacy review by the New Health Technology Assessment (nHTA) Committee for SmartPReP2 BMAC
(autologous bone marrow stem cell therapy for patients with cartilage defects, MOHW Notice No. 2012-1)
2011
- Appointed as the exclusive distributor in Korea for Anika Therapeutics Inc. (USA) for Hyalofast®, a hyaluronic acid–based 3D scaffold
- Hosted an International Stem Cell Conference: Harvest SmartPReP2 Korea Launching Symposium
- Company name changed to MIRA CO., LTD.
2000’s
2009
- Appointed as the exclusive distributor in Korea for Medik8, Pangaea Laboratories Ltd. (UK)
- Appointed as the exclusive distributor in Korea for Harvest Technologies Corp. (USA), a Harvard University–affiliated stem cell company
2006
- Appointed as the exclusive distributor in Korea for Dual Yellow Laser, NORSELD Pty Ltd. (Australia)
2005
- Appointed as the exclusive distributor in Korea for Beauty-Rent, COSMOMED Beauty-Rent GmbH (Germany)
2004
- Appointed as the exclusive distributor in Korea for SANSPA USA (USA)
2002
- Appointed as the exclusive distributor in Korea for SANSPA USA (USA)
2001
- Appointed as the exclusive distributor in Korea for LPG Systems S.A. (France)
1990’s
1998
- Appointed as the exclusive distributor in Korea for CARISMA Srl (Italy)
1997
- Incorporated as MIRA COSMETIC CO., LTD.
- Launched the SKIN MAN FULL franchise (MIRA Dermatology)
1996
- Appointed as the exclusive distributor in Korea for PHYTOBIODERMIE (France)
1994
- Appointed as the exclusive distributor in Korea for NEODERMA COSMETICS, ROLANDOS Enterprises Ltd. (Cyprus)
1991
- Appointed as the exclusive distributor in Korea for SAUNA ITALIA SPA (Italy)
1980’s
1988
- Appointed as the exclusive distributor in Korea for IPS Srl (Italy)
- Appointed as the exclusive distributor in Korea for SA.MAS. Srl (Italy)
1987
- Appointed as the exclusive distributor in Korea for SA.MAS. Srl (Italy)
1986
- Established Mira Dermatology Clinic
- Appointed as the exclusive distributor in Korea for FORMAGGIA Srl (Italy)
